Related Experiment Video
Updated: May 23, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Body Fluid-based Biomarkers for Cognitive Impairment in Parkinson's Disease
Ragini R1, Shatabdi Choudhury1, Krithika N C1
1Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Background:
Parkinson's disease (PD) is the second most common neurodegenerative disorder with cognitive impairment as a prime non-motor symptom. Biomarkers can assist in detecting cognitive impairment, which normally follows movement dysfunction, and also assist in the differentiation of PD patients with and without cognitive dysfunction, facilitating the early diagnosis and disease management while also allowing for timely therapeutic intervention.
Summary:
Here, we have reviewed the biomarkers of Parkinson's disease from different sources i.e., body fluids (CSF, blood, salivary, urine and tear) and tissues (gut and skin), along with the techniques used for the detection of these biomarkers. We further discuss the importance of biomarker validation and the significance of cohort studies in biomarker discoveries.
Key Message:
The chapter is aimed at updating the knowhow of the disease biomarkers that may assist differentiation of these overlapping entities.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction

